Skip to main content
. 2021 Mar 18;12(5):1379–1398. doi: 10.1007/s13300-021-01006-0

Table 4.

Costs of various activities that were performed to assist patients in the CG and the IG with severe and symptomatic hypoglycemia episodes at baseline and at the end of follow-up

Event type Cost per event (€) Control group (CG) Intervention group (IG)
Severe hypos Symptomatic hypos Severe hypos Symptomatic hypos
Baseline End of follow-up Baseline End of follow-up Baseline End of follow-up Baseline End of follow-up
Events
n = 26
Events
n = 22
Events
n = 133
Events
n = 135
Events
n = 26
Events
n = 1
Events
n = 133
Events
n = 12
PHV 25.8 26 670.8 20 516 90 2323.8 80 2065 0 1 25.8 82 2117.2 9 233
ER 241.0 18 4338 14 3375 22 5302 14 3374 21 5061 0 20 4820 1 241
EMS 128.5 26 3341 20 2570 22 2827 18 2313 30 3855 0 20 2570 1 128.5
FM/C-WD 78.6 14 1100.4 62 4873.2 52 4087.2 102 8017.2 72 5659.2 0 0 0
DHC 750 18 13,500 17 12,750 0 0 18 13,500 0 0 0
IDC Total cost (€) 22,950.2 24,084.2 14,540.0 15,769.2 28,075.2 25.8 9507.2 602.5

The costs were calculated based on average National Health Service rates, as already reported in [24]

PHV physician home visit, ER emergency room visit and treatment, EMS emergency medical service call/h, FM family member, C caregiver, WD working day, DHC daily hospitalization cost, IC insulin cost